True Link Financial Advisors, LLC Organon & Co. Transaction History

True Link Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $3,501 - $4,526	-115 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$28.67 - $37.13 $516 - $668	-18 Reduced 13.53%	115 $4,000
Q3 2021 Oct 29, 2021	SELL	$28.63 - $35.64 $572 - $712	-20 Reduced 13.07%	133 $4,000
Q2 2021 Aug 19, 2021	BUY	$28.45 - $38.0 $4,352 - $5,814	153 New	153 $5,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of True Link Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True Link Financial Advisors, LLC with notifications on news.